rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Continuous Renal Replacement Therapy

Rediff.com  »  News  »   Continuous Renal Replacement Therapy

  News for Continuous Renal Replacement Therapy

  • News

Sai Baba critical but stable, say Doctors

There has been a slight improvement in the health of Sathya Sai Baba though he still continues to be in a critical state, doctors attending on him said on Friday. "Sathya Sai Baba's vital......

Sai Baba's health improves, Puttaparthi relieved

Sathya Sai Baba's health showed signs of improvement on Thursday and doctors attending on him expressed satisfaction with his response to their treatment. A health bulletin issued in the evening by......

Sathya Sai Baba stable, Puttaparthi tense

According to the latest medical bulletin, spiritual leader Sathya Sai Baba, who was hospitalised ten days ago following lung and chest congestion, is responding to treatment. But the bulletin added......

Sathya Saibaba in critical condition: Doctors

Condition of Sri Sathya Saibaba, who was admitted to hospital following chest and lung congestion on March 28, has turned critical, doctors treating him said.According to an emergency medical......

Mahajan develops respiratory problem

Senior Bharatiya Janata Party leader Pramod Mahajan has developed an acute respiratory problem, leading to increase in ventilatory support on Monday, even as his condition remains 'very critical'.......
  Web results for Continuous Renal Replacement Therapy
Ultragenyx Announces Positive Results From a Long-Term Phase 1/2 Study of KRN23 in Adult Patients With X-Linked Hypophosphatemia

All Patients Continued to Demonstrate Increases in Serum Phosphorus and the Majority Maintained Levels in the Normal Range NOVATO, Calif., Sept.... ...

http://www.bizwireexpress.com/showstoryGNW.php?storyid=42867
Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Boston Scientific (NYSE:BSX) Intraday Stock Chart Today : Wednesday 10 September 2014 MARLBOROUGH, Mass. , Sept. 10, 2014 /PRNewswire/ --... ...

http://in.advfn.com/p.php?pid=nmona&article=63542052
Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy

WHITEHOUSE STATION, N.J. , Sept. 4, 2014 /PRNewswire/ --Merck (NYSE: MRK), known as MSD outside the United States and Canada , today announced that... ...

http://in.advfn.com/p.php?pid=nmona&article=63479130
Technologies and Global Markets

From the Wires Sep. 2, 2014 10:07 PM LONDON , Sept. 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:... ...

http://in.sys-con.com/node/3168816
Novartis' investigational heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in PARADIGM-HF trial

From the Wires Aug. 30, 2014 11:13 AM LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when... ...

http://in.sys-con.com/node/3166425

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z